Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  LHC Group, Inc.    LHCG

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

LHC Group, Inc. : LHC Group Earns Recognition From National Publications

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/12/2011 | 09:58pm CEST

LAFAYETTE, La., Dec. 12, 2011 (GLOBE NEWSWIRE) -- LHC Group Inc. (Nasdaq:LHCG), a national provider of home health and hospice services, has been honored as one of the nation's most successful companies by two national publications.

For the fifth consecutive year, LHC Group has been named one of "America's 100 Best Small Companies" by Forbes magazine. In addition, LHC Group has been recognized as one of the nation's "100 Fastest-Growing Companies" by Fortune magazine for the second consecutive year.

Keith G. Myers, chairman and CEO, said the national recognition is a tribute to the skill and compassion of the company's 8,000 employees at more than 300 locations in 19 states.

"At LHC Group, everything we do is centered on one principle: It's all about helping people," Myers said. "We've grown from a single home health agency in rural Louisiana into a national healthcare provider serving 80,000 patients every year, because we've never forgotten a simple fact - we're here to provide high-quality, compassionate health care to the men and women who put their trust in us."

Earlier this year, LHC Group also earned national recognition for its quality of care. Nearly 40 percent of the company's home health providers are rated among the nation's 2011 "HomeCare Elite," an independent ranking of home health quality and performance. The 2011 HomeCare Elite list, compiled annually by OCS HomeCare and DecisionHealth, names the top 25 percent of home health agencies in the United States.

LHC Group is also the only home health company in the country pursuing 100 percent Joint Commission accreditation. Established in 1988, The Joint Commission's home care accreditation program addresses a home care organization's performance in specific areas to help ensure patient care and services are provided in a safe manner.

About LHC Group Inc.

is a national provider of home health and hospice services, providing quality, cost-effective health care to patients within the comfort and privacy of their home or place of residence.  LHC Group provides a comprehensive array of post-acute healthcare services through home health, hospice and private duty locations in its home-based division and long-term acute care hospitals in its facility-based division.

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the company's future financial performance and the strength of the company's operations. Such forward-looking statements may be identified by words such as "continue," "expect" and similar expressions. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including changes in reimbursement, changes in government regulations, changes in LHC Group's relationships with referral sources, increased competition for LHC Group's services, increased competition for joint venture and acquisition candidates, changes in the interpretation of government regulations and other risks set forth in Item 1A.  Risk Factors in LHC Group's Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission. LHC Group undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Amy Stevens

         (337) 233-1307
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LHC GROUP, INC.
04/20 LHC GROUP, INC. (NASDAQ : LHCG) Files An 8-K Departure of Directors or Certain O..
04/20 LHC GROUP, INC : Change in Directors or Principal Officers (form 8-K)
04/20 LHC Group Announces First Quarter 2017 Earnings Release and Conference Call D..
04/06 Wilson Medical Center Hospice under new ownership in joint venture
04/05 LHC GROUP, INC. (NASDAQ : LHCG) Files An 8-K Departure of Directors or Certain O..
04/05 LHC GROUP, INC : Change in Directors or Principal Officers, Financial Statements..
04/03 LHC Group Announces Home Health and Hospice Joint Venture With Pleasant Valle..
04/03 LHC : forms joint venture with West Virginia hospital
03/29 LHC : and Lourdes expand partnership to include hospice care
03/29 LHC : Belpre home health provider announces name change
More news
Sector news : Ambulance & Emergency Services
04/27 European shares fall as ECB stands pat, banks drop
04/25 Fresenius picks up M&A pace with Akorn, Merck KGaA deals
04/25DJFRESENIUS : Makes Two Acquisitions to Boost Kabi Clinical Unit
04/24DJFresenius Kabi To Strengthen And Diversify Product Portfolio By Acquiring Ako..
04/17DJPLEASE DISREGARD HCA REVENUE, NET IN : 30 a.m. ET
More sector news : Ambulance & Emergency Services
News from SeekingAlpha
03/10 BIOTECH FORUM DAILY DIGEST : TG Therapeutics Continues To Soar, Buyout Rumors Su..
03/09 LHC Group's (LHCG) CEO Keith Myers on Q4 2016 Results - Earnings Call Transcr..
03/09 LHC Group 2016 Q4 - Results - Earnings Call Slides
03/08 LHC Group beats by $0.01, beats on revenue
03/07 Notable earnings after Wednesday?s close
Advertisement
Financials ($)
Sales 2017 1 009 M
EBIT 2017 78,9 M
Net income 2017 38,8 M
Debt 2017 0,70 M
Yield 2017 -
P/E ratio 2017 25,07
P/E ratio 2018 22,39
EV / Sales 2017 0,98x
EV / Sales 2018 0,91x
Capitalization 983 M
More Financials
Chart LHC GROUP, INC.
Duration : Period :
LHC Group, Inc. Technical Analysis Chart | LHCG | US50187A1079 | 4-Traders
Full-screen chart
Technical analysis trends LHC GROUP, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 55,6 $
Spread / Average Target 2,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Keith G. Myers Chairman & Chief Executive Officer
Donald Dwayne Stelly President & Chief Operating Officer
Joshua L. Proffitt Chief Financial Officer, Treasurer & Executive VP
Angie M. Begnaud Chief Clinical Officer & Executive Vice President
John M. Thompson Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
LHC GROUP, INC.18.49%983
FRESENIUS SE & CO KGAA0.09%44 843
HCA HOLDINGS INC12.86%30 947
FRESENIUS MEDICAL CARE..2.16%27 538
QUEST DIAGNOSTICS INC15.20%14 471
LABORATORY CORP. OF AM..8.19%14 206
More Results